Reval Releases HedgeRx Version 7.0
Reval has announced the release of version 7.0 of HedgeRx with its CICA 3865 module to address the stringent new derivative reporting requirements under Canadian GAAP. The company says that Canadian companies will be able to run the more complex effectiveness reporting requirements, including an automated regression feature, as the easier methods under the so called Short-cut rule and Critical Terms Match rule have fallen under scrutiny with the SEC and Big 4 accounting firms. The module also includes the CICA 3865 Doctor which is a step-by-step wizard to help form not only the proper hedging strategy and approach but also creates the at-inception documentation.
Comments are closed.